CEACAM5 and colorectal carcinoma: The following factors associated with better outcomes in patients with S-PM CRC were identified by performing univariate Cox analysis: carcinoma embryonic antigen (CEA) of <5.0 ng/mL (P = 0.008), CA199 of <37.0 U/mL (P = 0.008), CC-0/1 (P < 0.001), HIPEC (P = 0.001), and wtBRAF (P < 0.001) (Table 3).